Fish-eye disease: Another under-recognized cause of familial corneal opacification

S. Kapoor

DOI: https://doi.org/10.3109/13816810.2015.1059461

2016-02-08

Ophthalmic Genetics

Abstract:A common cause of familial corneal opacification that is frequently overlooked is “Fish eye disease” (FED). FED is a unique clinical entity characterized by HDL deficiency and corneal opacification that was first reported nearly 35 years ago. Dimick and co-authors have recently confirmed that FED occurs secondary to mutations in the LCAT gene. Most affected individuals are homozygous or heterozygous for a Thr-Ile mutation at codon 123 of the LCAT gene. Most cases are familial as recently confirmed by Clerc and co-authors. Anomalous cholesterol esterification of non-HDL lipoproteins in the serum is characteristically seen in affected patients. FED may manifest at any age. For instance, Tateno and colleagues have recently reported initial presentation of FED in a 57-year-old male. Corneal opacification can be appreciated on slit lamp examination in most patients with FED. The opacities usually start appearing around 20 years of age. Visual acuity is markedly reduced. Individuals affected by FED are typically not at an increased risk of developing premature coronary heart disease. However, rarely premature coronary artery disease may occur as recently reported by Kuivenhoven and co-authors. FED is characterized by the absence of splenomegaly as well as anemia – these clinical and laboratory signs help in differentiating it from “familial LCAT deficiency.” In addition, renal function is mostly normal in patients with FED. Consanguinity may have a major role to play in evolution of the disease. Blood tests reveal marked HDL deficiency. Elkhalil and colleagues have recently shown that apolipoprotein (apo) AI concentration is markedly attenuated. In addition, serum triglycerides as well as VLDL are significantly elevated. Histological examination of affected cornea reveals small vacuoles that are predominantly seen in the anterior stroma. Therapy in patients with FED involves institution of medications to decrease serum LDL-C levels. Penetrating keratoplasty may be necessary in some patients as recently reported by De Smedt and co-authors. As is obvious from the above discussion, FED is another rare and unique cause of familial corneal opacification. It should be considered high in the differential in patients presenting with familial corneal opacification. Declaration of Interest